Sentinal4D

1 known investors

Sentinal4D applies deep learning to 3D and 4D single-cell microscopy, analyzing cell shape and morphodynamic patterns to predict drug response, mechanism of action, toxicity, and other outcomes. Delivered as a SaaS platform with an annotated library of cancer cell imaging, it targets pharmaceutical and biomedical R&D teams working in drug discovery and biomarker development.